Research
Mary Kay Foundation Awards $100,000 Grant
July 20, 2021
The Mary Kay Foundation awarded $100,000 to Zhijie “Jason” Liu, PhD, who will leverage the grant to study estrogen receptor alpha (ERα), a biomarker of breast cancer.
International Grant Funds Pediatric Cancer Research
July 20, 2021
Alexander Bishop, DPhil, and a colleague in Scotland were awarded a grant from the Stand Up To Cancer and Cancer Research UK’s Pediatric Cancer New Discoveries Challenge, which funds international teams studying hard-to-treat pediatric cancer. The scientists are teaming up to investigate a unique biological hallmark of Ewing sarcoma.
Breast Cancer/Radiation Researcher Recruited
July 20, 2021
David Gius, MD, PhD, a breast cancer and radiation researcher, joined the Mays Cancer Center. He was recruited with a $6 million senior investigator recruitment grant awarded in 2020 by CPRIT.
Childhood Chemo Alters Heart’s Caretaker Cells
July 20, 2021
Senior author Gregory Aune, MD, PhD, released findings by his team showing that cancer chemotherapy changes the function of cells that repair heart injury. Twenty percent of children treated with anthracyclines suffer heart failure later in life.
CPRIT Awards $10.3 Million for Five Grants
July 20, 2021
A $10.3 million CPRIT award to the Mays Cancer Center included $6 million to recruit David Gius, MD, PhD, a breast cancer and radiation oncology researcher, and $2 million to recruit Peng Zhao, PhD, a liver cancer researcher. This award also included three grants to individual cancer researchers: Dmitri Ivanov, PhD; Mingjiang Xu, MD, PhD, and Luiz Penalva, PhD.
Research Reveals Role of Protein in Kidney Cancer
July 20, 2021
Dharam Kaushik, MD, and his research team confirmed the role of a certain protein in the development of high-grade kidney cancer. Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase-4 (Nox4) — often referred to as Nox4 — was found to concentrate in the nucleus of human kidney cancer cells.
Fighting Cancer Cells That Grow with Therapy
July 20, 2021
Daruka Mahadevan, MD, PhD, leader of hematology and medical oncology care at the Mays Cancer Center, co-authored a paper explaining that two cancer-causing genes, called c-Myc and BCL2, are operative in “double-hit” high-grade lymphomas, which are incurable.
2019 Discovery of the Year presented to Dr. Zhijie “Jason” Liu
June 15, 2020
Zhijie “Jason” Liu, Ph.D., assistant professor of molecular medicine and CPRIT Scholar in Cancer Research, earned the 2019 Discovery of the Year Award from the Mays Cancer Center for his breast cancer research.
2019 Clinical Investigator of the Year award recognizes GI cancer expert
June 15, 2020
Medical Oncologist Sukeshi Patel Arora, M.D., was named the Mays Cancer Center’s 2019 Clinical Investigator of the Year for her work with gastrointestinal cancer patients.
Internationally known biochemist building world-class genome repair program
June 15, 2020
Renowned biochemist Patrick Sung, D.Phil., and his team are developing a nationally recognized genome repair program designed to create new therapeutics to treat difference types of cancer.
Researchers, physicians working together to develop new ways to fight liver cancer
June 15, 2020
Liver cancer tumors removed by surgeons are being studied by scientists with the goal of finding better ways to prevent, diagnose and treat hepatocellular carcinoma (HCC) in Hispanics in South Texas.
Clinical trial tests FDA-approved drug to treat diffuse large B-cell lymphoma
June 15, 2020
Ricardo Aguiar, M.D., Ph.D., professor of medicine and vice chief for research in the Division of Hematology and Medical Oncology, is conducting research with the goal of finding a cure for patients who are diagnosed with diffuse large B-cell lymphoma.